In vitro anticancer activity of a head-to-toe constructed heterobimetallic [CoFeL]2+ metallocylinder

Hayden B. Gearing,Dylan Giffard,Matthew P. Sullivan,Julia Stjärnhage,Stephen M.F. Jamieson,Tilo Söhnel,James D. Crowley,L. James Wright,Christian G. Hartinger
DOI: https://doi.org/10.1080/10610278.2024.2396489
2024-09-04
Supramolecular Chemistry
Abstract:[M 2 L 3 ]-type metallo-supramolecular architectures (MSAs) are widely explored for their biological activity, whereas data on non-symmetric, heterobimetallic [MM'L 3 ] structures is comparatively rare. [M 2 L 3 ] compounds are known to form helicates and/or mesocates. Here, we report the self-assembly of a discrete non-symmetrical, heterobimetallic MSA by combination of an amine-functionalised cobalt(III)-tris((picolinamido)ethyl)amine (PICTREN) base unit with FeCl 2 and 2,2'-bipyridine-5-carboxaldehyde. NMR spectroscopy in tandem with computational studies revealed the formation of a mesocate rather than a helicate. The ability of the heteromesocate to bind to DNA was examined by gel electrophoresis with pUC19 plasmid DNA, which showed DNA binding although longer incubation periods were required than found for a known DNA-interacting helicate. The mesocate displayed promising antiproliferative activity in cancer cells, including a cisplatin-resistant cell line, with IC 50 values in the 17–26 μM range. Lower biological activity of the mesocate compared to a metallocylinder reference and cisplatin may be explained by differences in the DNA interactions. This work further supports efforts to establish methods with which to construct heterobimetallic complexes, establishing the utility of the self-assembly method in [M 2 L 3 ]-type assemblies using the cobalt(III)-PICTREN platform as a robust building block towards more complex assemblies of the [MM'L]-type.
chemistry, multidisciplinary
What problem does this paper attempt to address?